Authors
Loading...
Retrospective analysis shows thiotepa dose influences graft versus host disease and relapse risk in AML transplantation.
Ferhat et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: